Vaxart, Inc.
VXRT
$0.3181
-$0.0258-7.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.19M | 4.93M | 6.40M | 2.18M | 3.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.19M | 4.93M | 6.40M | 2.18M | 3.25M |
| Cost of Revenue | 22.65M | 15.07M | 17.48M | 19.01M | 14.71M |
| Gross Profit | -7.47M | -10.13M | -11.08M | -16.83M | -11.46M |
| SG&A Expenses | 4.02M | 4.34M | 5.18M | 7.24M | 5.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.68M | 19.41M | 22.66M | 26.25M | 20.15M |
| Operating Income | -11.49M | -14.48M | -16.26M | -24.07M | -16.90M |
| Income Before Tax | -11.81M | -14.06M | -16.45M | -24.37M | -17.20M |
| Income Tax Expenses | 176.00K | 18.00K | 21.00K | 45.00K | 174.00K |
| Earnings from Continuing Operations | -11.99M | -14.08M | -16.47M | -24.42M | -17.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.99M | -14.08M | -16.47M | -24.42M | -17.38M |
| EBIT | -11.49M | -14.48M | -16.26M | -24.07M | -16.90M |
| EBITDA | -9.26M | -12.25M | -14.04M | -21.89M | -14.57M |
| EPS Basic | -0.05 | -0.06 | -0.09 | -0.14 | -0.12 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.06 | -0.09 | -0.08 |
| EPS Diluted | -0.05 | -0.06 | -0.09 | -0.14 | -0.12 |
| Normalized Diluted EPS | -0.03 | -0.04 | -0.06 | -0.09 | -0.08 |
| Average Basic Shares Outstanding | 227.58M | 227.45M | 184.70M | 168.81M | 141.85M |
| Average Diluted Shares Outstanding | 227.58M | 227.45M | 184.70M | 168.81M | 141.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |